Gioacchin Iannolo

Prof. Gioacchin Iannolo

Department of Research, Mediterranean Institute for Transplantation and Advanced Specialized Therapies (ISMETT-IRCCS), Palermo, Italy
orcid

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 February 1998 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
SSSilvano Sozzani
Silvano Sozzani
SGSilvia Ghezzi
Silvia Ghezzi
Gioacchin IannoloGioacchin Iannolo
Gioacchin Iannolo
WLWalter Luini
Walter Luini
ABAlessandro Borsatti
Alessandro Borsatti
Alberto MantovaniAlberto Mantovani
Alberto Mantovani
The immunosuppressive and antiinflammatory cytokine interleukin (IL) 10 selectively upregulates the expression of the CC chemokine receptors CCR5, 2, and 1 in human monocytes by prolonging their mRNA half-life. IL-10–stimulated monocytes display an increased number of cell surface receptors for, and better chemotactic responsiveness to, relevant agonists than do control cells. In addition, IL-10–stimulated monocytes are more efficiently infected by HIV BaL. This effect was associated to the enhancement of viral entry through CCR5. These data add support to an emerging paradigm in which pro- and antiinflammatory molecules exert reciprocal and opposing influence on chemokine agonist production and receptor expression.

Verified
Journal Article
Open access
PDF file
VMVitale Miceli
Vitale Miceli
MBMatteo Bulati
Matteo Bulati
Gioacchin IannoloGioacchin Iannolo
Gioacchin Iannolo
GZGiovanni Zito
Giovanni Zito
AGAlessia Gallo
Alessia Gallo
PCPier Giulio Conaldi
Pier Giulio Conaldi
Mesenchymal stromal/stem cells (MSCs) are multipotent adult stem cells that support homeostasis during tissue regeneration. In the last decade, cell therapies based on the use of MSCs have emerged as a promising strategy in the field of regenerative medicine. Although these cells possess robust therapeutic properties that can be applied in the treatment of different diseases, variables in preclinical and clinical trials lead to inconsistent outcomes. MSC therapeutic effects result from the secretion of bioactive molecules affected by either local microenvironment or MSC culture conditions. Hence, MSC paracrine action is currently being explored in several clinical settings either using a conditioned medium (CM) or MSC-derived exosomes (EXOs), where these products modulate tissue responses in different types of injuries. In this scenario, MSC paracrine mechanisms provide a promising framework for enhancing MSC therapeutic benefits, where the composition of secretome can be modulated by priming of the MSCs. In this review, we examine the literature on the priming of MSCs as a tool to enhance their therapeutic properties applicable to the main processes involved in tissue regeneration, including the reduction of fibrosis, the immunomodulation, the stimulation of angiogenesis, and the stimulation of resident progenitor cells, thereby providing new insights for the therapeutic use of MSCs-derived products.

1 November 2004 in The Lancet
Verified
Journal Article
Closed access
GAGiulio Alessandri
Giulio Alessandri
SPStefano Pagano
Stefano Pagano
ABAlessandra Bez
Alessandra Bez
ABAnna Benetti
Anna Benetti
SPStefano Pozzi
Stefano Pozzi
EPEugenio Parati
Eugenio Parati

1 January 2004 in Molecular Biology of the Cell
Verified
Journal Article
Open access
PDF file
NONina Offenhäuser
Nina Offenhäuser
ABAlessandro Borgonovo
Alessandro Borgonovo
Andrea DisanzaAndrea Disanza
Andrea Disanza
PRPascale Romano
Pascale Romano
IPIsabella Ponzanelli
Isabella Ponzanelli
GSGiorgio Scita
Giorgio Scita
Sos-1, a guanine nucleotide exchange factor (GEF), eps8 and Abi1, two signaling proteins, and the lipid kinase phosphoinositide 3-kinase (PI3-K), assemble in a multimolecular complex required for Rac activation leading to actin cytoskeletal remodeling. Consistently, eps8 –/– fibroblasts fail to form membrane ruffles in response to growth factor stimulation. Surprisingly, eps8 null mice are healthy, fertile, and display no overt phenotype, suggesting the existence of functional redundancy within this pathway. Here, we describe the identification and characterization of a family of eps8-related proteins, comprising three novel gene products, named eps8L1, eps8L2, and eps8L3. Eps8Ls display collinear topology and 27–42% identity to eps8. Similarly to eps8, eps8Ls interact with Abi1 and Sos-1; however, only eps8L1 and eps8L2 activate the Rac-GEF activity of Sos-1, and bind to actin in vivo. Consistently, eps8L1 and eps8L2, but not eps8L3, localize to PDGF-induced, F-actin–rich ruffles and restore receptor tyrosine kinase (RTK)-mediated actin remodeling when expressed in eps8 –/– fibroblasts. Thus, the eps8Ls define a novel family of proteins responsible for functional redundancy in the RTK-activated signaling pathway leading to actin remodeling. Finally, the patterns of expression of eps8 and eps8L2 in mice are remarkably overlapping, thus providing a likely explanation for the lack of overt phenotype in eps8 null mice.

1 August 1999 in The International Journal of Biochemistry & Cell Biology
Verified
Journal Article
Closed access
ASAnna Elisabetta Salcini
Anna Elisabetta Salcini
HCHong Chen
Hong Chen
Gioacchin IannoloGioacchin Iannolo
Gioacchin Iannolo
PCPietro De Camilli
Pietro De Camilli
PFPier Paolo Di Fiore
Pier Paolo Di Fiore

1 April 2008 in Critical Reviews in Oncology/Hematology
Verified
Journal Article
Closed access
Gioacchin IannoloGioacchin Iannolo
Gioacchin Iannolo
CCConcetta Conticello
Concetta Conticello
LMLorenzo Memeo
Lorenzo Memeo
RMRuggero De Maria
Ruggero De Maria